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OBJECTIVE — Despite the importance of self-management support (SMS), few studies have
comparedSMSinterventions,involveddiversepopulations,orentailedimplementationinsafety
netsettings.WeexaminedtheeffectsoftwoSMSstrategiesacrossoutcomescorrespondingtothe
Chronic Care Model.
RESEARCH DESIGN AND METHODS — A total of 339 outpatients with poorly con-
trolled diabetes from county-run clinics were enrolled in a three-arm trial. Participants, more
than half of whom spoke limited English, were uninsured, and/or had less than a high school
education, were randomly assigned to usual care, interactive weekly automated telephone self-
management support with nurse follow-up (ATSM), or monthly group medical visits with
physician and health educator facilitation (GMV). We measured 1-year changes in structure
(Patient Assessment of Chronic Illness Care [PACIC]), communication processes (Interpersonal
Processes of Care [IPC]), and outcomes (behavioral, functional, and metabolic).
RESULTS — Compared with the usual care group, the ATSM and GMV groups showed
improvements in PACIC, with effect sizes of 0.48 and 0.50, respectively (P  0.01). Only the
ATSM group showed improvements in IPC (effect sizes 0.40 vs. usual care and 0.25 vs. GMV,
P  0.05). Both SMS arms showed improvements in self-management behavior versus the usual
carearm(P0.05),withgainsbeinggreaterfortheATSMgroupthanfortheGMVgroup(effect
size 0.27, P  0.02). The ATSM group had fewer bed days per month than the usual care group
(1.7days,P0.05)andtheGMVgroup(2.3days,P0.01)andlessinterferencewithdaily
activities than the usual care group (odds ratio 0.37, P  0.02). We observed no differences in
A1C change.
CONCLUSIONS — Patient-centered SMS improves certain aspects of diabetes care and
positively inﬂuences self-management behavior. ATSM seems to be a more effective communi-
cation vehicle than GMV in improving behavior and quality of life.
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S
elf-management support (SMS) is a
cornerstone of chronic disease care,
encompassing strategies such as in-
dividualized assessment, collaborative
goal-setting, skills enhancement, access
to resources, and continuity of care (1,2).
Efﬁcacy studies of disease management
that include SMS have shown improved
patient satisfaction, knowledge, self-
efﬁcacy, coping, and behavior but have
less consistently shown improved physi-
ological outcomes or functional status
(3,4). The complex, multifaceted nature
ofinterventionshasprecludedidentifying
effects of the SMS component. Few stud-
ies have involved ethnically diverse, so-
cioeconomically vulnerable populations
(5), have taken place in safety net settings
(6,7), or have compared alternate forms
of SMS or measured effects across a range
of outcomes (5).
“Practicalclinicaltrials,”studiesofev-
idence-based, reproducible interventions
designed to enable rigorous evaluation
with respect to both reach and effective-
ness, can address these limitations (8).
The Improving Diabetes Efforts Across
Language and Literacy (IDEALL) project
wasapracticalclinicaltrialconductedina
safetynethealthsystemthatimplemented
two SMS strategies (automated telephone
self-management support [ATSM] and
group medical visits [GMV]) as adjuncts
to care, and compared them with usual
care.Wereporteffectivenessresultsofthe
IDEALL project across a range of diabetes
outcomes.
RESEARCH DESIGN AND
METHODS— The rationale and de-
sign of the IDEALL project have been de-
scribed previously (9,10). The project
emanated from a strategic initiative to im-
prove diabetes care in the Community
Health Network of San Francisco, the in-
tegrated delivery system of the San Fran-
cisco Department of Public Health.
Interventions
We selected SMS strategies with different
approaches to engaging patients. ATSM
uses technology to provide surveillance,
education,andpatientactivation.Efﬁcacy
studies of ATSM linked to nurse care
management indicate improvements in
satisfaction and functional status (11,12).
GMVusesagroupprocesstoprovidesup-
port, education, and patient activation.
GMV has been shown to improve self-
efﬁcacy and functional status among se-
lected patients with chronic diseases
(13,14). Both strategies are rooted in self-
efﬁcacy theory, share objectives charac-
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promote collaborative goal-setting in
the form of behavioral “action plans”
(1,5), wherein patients set short-term
self-management goals. SMS models
were delivered in English, Spanish, and
Cantonese.
Detailed descriptions of interven-
tions and related materials are available
(10). Participants randomly assigned to
ATSM received weekly, automated
(prerecorded) telephone calls over 39
weeks (9 months). Patient responses
triggered either immediate, automated
health education messages and/or sub-
sequent nurse phone follow-up (Fig.
A1, available in an online appendix at
http://care.diabetesjournals.org/cgi/content/
full/dc08-0787/DC1). Each ATSM call
takesbetween6and10minforpatientsto
complete.Therewerenomonetaryincen-
tives associated with ATSM calls. The
GMV arm involved 90-min monthly ses-
sions over 9 months, with 6–10 partici-
pants, cofacilitated by a primary care
physician and health educator (Fig. A2,
available in an online appendix). GMV
participants received bus tokens and
healthy snacks.
Medication intensiﬁcation was not an
explicit goal of either SMS model. All pa-
tient interactions between ATSM care
managersandGMVcofacilitators,includ-
ing action plans created and achieved,
weredocumentedviaastandardizedSMS
record that also served to communicate
with the patient’s physician. There were
no explicit expectations for either SMS
model regarding comanagement with the
primary care physician.
Recruitment
Details regarding recruitment and eligi-
bilitywerereviewedelsewhere(9,10).Be-
tweenJune2003andDecember2004,we
createdaregistrytoidentifyadultpatients
with type 2 diabetes in the Community
Health Network of San Francisco, who
spoke English, Spanish, or Cantonese,
made 1 primary care visit in the prior
year, and had a most recent A1C 8.0%.
Primary care physicians excluded pa-
tients who had moved away or died, had
moderate to severe dementia, or were not
expected to live through the year. Re-
search assistants approached patients for
participation and to further assess for ex-
clusions,including1)anticipatedtravelof
3monthsinupcomingyear,2)tooillor
unable to travel to a GMV, 3) no phone
access, 4) self-reported hearing impair-
ment, and 5) visual acuity of 20/100 or
inability to follow instructions on a tele-
phone keypad.
Eligible patients attended a study en-
rollment visit at the San Francisco Gen-
eral Hospital Clinical Research Center.
Informed consent was obtained after a
language-concordant document written
at the 6th-grade level was read to poten-
tial participants. Patients were allocated
using stratiﬁed (on languages) blocked
randomization. Patients were encour-
agedtoseetheirregulardoctorasusual.
Participants received $15 and $25 for
the baseline and 1-year follow-up re-
search visits, respectively. The study
was approved by the institutional re-
view board of the University of Califor-
nia, San Francisco.
Study variables
We developed a questionnaire in English,
translated it into Spanish and Cantonese,
and then back-translated in an iterative
fashion to achieve concordance in mean-
ing. The questionnaire assessed the char-
acteristics shown in Table 1. Health
literacy was measured in English and
Spanish only using the short-form Test of
FunctionalHealthLiteracyinAdults(15).
We categorized scores of 0 to 22 as lim-
ited health literacy and of 23 to 36 as ad-
equate health literacy.
Outcomes
Our primary outcome was 1-year
change in self-management behavior.
We further explored a range of out-
comes corresponding to levels of the
Chronic Care Model (CCM) (2). CCM is
an ecological model describing factors,
including self-management support,
that can improve functional and clinical
outcomes. We used a set of scales cor-
responding to 1) structure, 2) process,
and 3) health outcomes.
To assess patients’ perspectives re-
garding the degree to which structure of
care was aligned with the CCM, we used
the Patient Assessment of Chronic Illness
Care (PACIC) instrument (16) and trans-
formed summary scores to a 100-point
scale, with higher scores representing
greaterCCMalignment.Wealsoexplored
effects on individual PACIC subscales.
To assess patients’ perspectives re-
garding the degree to which processes of
care were aligned with the CCM, we used
the Diabetes Quality Improvement Pro-
gram diabetes self-efﬁcacy measure over
the prior year (17) usinga0t o1 0 0scale.
We used the Interpersonal Processes of
CareforDiversePopulations(IPC)instru-
ment (18) to capture patient reports of
providers’ communication over the prior
year and generated a total IPC score on a
100-point scale. We also explored effects
on individual IPC subscales.
Wegroupedhealthoutcomesintobe-
havioral, functional, and metabolic out-
comes. To assess self-management
behavior, we used a validated instrument
that asks on how many of the previous 7
days the individual performed recom-
mended activities: eating healthy foods,
following a diabetic diet, exercising, self-
monitoring of blood glucose, and caring
for one’s feet (19). Because our research
with this population identiﬁed high rates
of self-reported medication adherence
(18), for parsimony, we did not include
this item. We generated weekly self-care
scores ranging from 0 to 7, with higher
scores corresponding to greater number
of days carrying out recommended be-
haviors. For exercise, participants also es-
timated minutes of moderate and
vigorous physical activity on each of the
days.
For functional status, we obtained re-
ports of days in the prior month partici-
pants“spentmostofthedayinbeddueto
health problems” and the extent to which
diabetes prevented them from carrying
outnormaldailyactivities(diabetesinter-
ference), using a 5-point Likert-type scale
ranging from “not at all” to “completely”
(11,12,20). We measured quality of life
usingtheShortForm(SF)-12instrument,
transforming physical and mental health
to 0–100 scales.
For metabolic outcomes, at baseline
and at 1 year, we measured A1C (high-
performance liquid chromatography
method; Bio-Rad, Hercules, CA). Both
systolic(SBP)anddiastolicbloodpressure
(DBP) were measured using calibrated au-
tomated cuffs (Criticon Dinamap). We cal-
culated BMI by measuring weight and
heightwithoutshoesandwithlightcloth-
ing and an empty bladder. For the small
number of participants who did not at-
tend follow-up assessments, we obtained
A1C, blood pressure, and weight by ab-
stractingchartsforvaluesobtainedwithin
3 months before or after the 12-month
follow-up time.
Statistical analyses
Weassessedsuccessofrandomizationus-
ing t tests, 
2 tests, and Fisher’s exact test
to compare baseline characteristics across
study arms. We report the degree of en-
gagement with each intervention, mea-
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responded to an ATSM call or attended a
GMV and the mean number of behavioral
action plans generated and achieved.
Moredetaileddescriptionsofengagement
with the interventions can be found in a
companion article (10).
We measured 1-year change for each
outcome in each study arm. We present
mean values and 1-year changes in mean
scale scores. For physical activity mea-
sures, in addition to reporting changes in
minutes per week, we calculated the dif-
ference in the proportion of subjects who
met minimum standards of 30 min of
moderateorvigorousphysicalactivity3
times/week, as recommended in national
guidelines. For bed days, because of the
nonparametric distribution, we report
median values. For diabetes interference,
we measured the proportion reporting
Table 1—Baseline characteristics: IDEALL participants
All
participants ATSM GMV Usual care P values
n 339 112 113 114
Age (years) 56.1  12.0 55.9  12.7 56.5  11.4 55.8  11.8 0.9
Women 59.0 58.0 63.7 55.3 0.4
Ethnic group 0.5
Asian 23.3 26.8 21.2 21.9
African American 20.6 14.3 23.9 23.7
White/Latino 46.9 46.4 46.0 48.3
White/non-Latino 7.7 9.8 8.0 5.3
Other/unknown 1.5 2.7 0.9 0.9
Language
English 45.4 46.4 45.1 44.7 1.0
Spanish 43.1 42.0 43.4 43.9
Cantonese 11.5 11.6 11.5 11.4
Health literacy*
Limited 58.8 51.0 57.1 68.0 0.1
Adequate 41. 49.0 42.9 32.0
Education
Up to some high school 54.3 51.8 55.8 55.3 0.6
High school graduate/GED 17.1 14.3 17.7 19.3
 Some college 28.6 33.9 26.6 25.4
Insurance
Medicaid 19.8 20.5 22.1 16.7 0.9
Medicare 21.5 19.6 23.0 21.9
Uninsured 50.2 50.0 46.0 54.4
Other 8.6 9.8 8.9 7.0
Income
$5,000 28.6 26.9 31.6 27.3 0.4
$5,000–$10,000 31.8 31.5 33.7 30.3
$10,000–$20,000 23.7 18.0 23.2 29.3
$20,000–$30,000 9.2 14.6 6.3 7.1
$30,000 6.7 9.0 5.2 6.0
Diabetes duration (years) 9.5  7.4 9.1  7.3 9.2  6.8 10.4  8.1 0.3
Mean outpatient visits, prior year 14.1 13.3 15.3 13.7 0.3
Diabetic educator visit, prior year 53.4 58.0 49.6 53.5 0.4
Nutritionist visit, prior year 37.5 34.8 39.8 37.7 0.7
Diabetes treatment regimen 0.8†
Diet only 1.2 0.0 0.9 2.7
Oral agents only 60.8 63.4 59.3 59.8
Insulin only 10.1 10.7 9.7 9.8
Insulin and oral agents 27.9 25.9 30.1 27.7
Poor or fair health 76.4 74.1 77.0 78.1 0.8
A1C 9.5  2.0 9.3  1.8 9.4  2.0 9.8  2.0 0.2
Blood pressure
SBP 140.0  20.8 137.8  21.5 143.5  20.0 138.7  20.7 0.1
DBP 77.3  12.0 75.7  12.1 78.4  12.7 77.8  11.2 0.2
BMI 31.5  10.0 30.3  6.7 31.9  8.2 32.3  13.5 0.3
DataaremeansSDor%.*HealthliteracyisbasedontheshortversionoftheTestofFunctionalHealthLiteracyinAdultsscale,exceptforCantonesepatients(n
39), for whom scores were not obtained. †Fisher’s exact test.
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with daily activities.
To test intervention effects, we com-
pared differences in change across the
three arms; analyses were conducted on
an intent-to-treat basis. In tables, we
present raw (unadjusted) values at base-
line and 1 year and calculate differences
foreachinterventionarmrelativetousual
careandforATSMversusGMV,adjusting
only for baseline values for each scale. To
enable interpretation of effects that in-
volve scales, we also calculated standard-
izedeffectsizes.Forcontinuousvariables,
we used linear regression; for dichoto-
mous variables, we used logistic regres-
sion. For bed days, we used negative
binomial models to calculate log mean
differences and generated incidence rate
ratios.
We powered the study to detect a dif-
ference between any of the three arms of
0.5 days/week in diabetes self-manage-
mentbehavior,ourprimaryoutcome.We
determined that 339 subjects would re-
sultin100subjectsineacharmattheend
of the study (n  300), providing 80%
power to detect a difference in diabetes
self-care of 0.49 days/week, using two-
tailedtests,of0.05,andBonferronicor-
rection for three group comparisons.
RESULTS— We approached 557 po-
tential subjects, 70 of whom refused, 90
of whom were not eligible, and 58 of
whom were potentially eligible but did
notattendthestudyenrollmentvisit(Fig-
ure A3, available in an online appendix).
Thus, 339 (61%) subjects enrolled and
were randomly assigned to ATSM (n 
112), GMV (n  113), or usual care (n 
114). Participants had a mean age of 56
years, more than half had some high
school education or less, half lacked
health insurance, and the majority re-
ported incomes $30,000 (Table 1). A
roughly equal percentage spoke English
or Spanish, followed by Cantonese.
Among English and Spanish speakers,
morethanhalfhadlimitedhealthliteracy.
A1C at enrollment was 9.5%, blood pres-
sure was 140/77 mmHg, and BMI was
31.5 kg/m
2. There were no statistically
signiﬁcant differences in baseline charac-
teristics across arms.
Of the subjects, 305 (90%) com-
pletedfollow-upinterviewsat1year(Fig-
ure A3). Three participants died during
thestudyperiodineachofthethreearms.
Participants lost to follow-up were
younger (51.7 vs. 56.5 years, P  0.02)
but otherwise were no different at P 
0.05.PairedvaluesforA1Cwereavailable
for 88.2% of the sample, blood pressure
for 94.1%, and BMI for 92.3%.
Engagement with interventions
Of the 112 randomly assigned subjects,
105(94%)completed1ATSMcall.The
mean number of ATSM calls completed
among ever users was 21.9 of 39 auto-
mated calls delivered. Among ATSM us-
ers, 100 (95%) received 1 care manager
call-back, and the mean number of call-
backswas9.2.Ofthese,88(88%)created
1actionplan,withameanof5.2.Partial
or complete success was reported to care
managers on a mean of 2.5 action plans.
Of the 113 randomized participants,
78 (69%) attended 1 GMV. The mean
number of GMVs attended among ever
users was 4.8 of 9 GMVs offered. Among
GMV attendees, 69 (89%) created 1 ac-
tion plan. This subgroup generated a
mean of 3.2 action plans and reported
partial or complete success to GMV facil-
itators on a mean of 1.6. Across both SMS
interventions, exercise and/or diet consti-
tuted the majority of action plans.
Effects on structure and processes of
care
Both ATSM and GMV participants dem-
onstrated robust improvements relative
to usual care participants in PACIC (P 
0.0001), with standardized effect sizes of
0.51forATSMversususualcareand0.53
for GMV versus usual care (Table 2). No
signiﬁcant differences were observed be-
tween ATSM and GMV participants in
overall PACIC change. For PACIC sub-
scales, both ATSM and GMV participants
demonstrated signiﬁcant improvements
relative to usual care participants in de-
livery system/practice design, goal set-
ting, problem-solving, and follow-up/
coordination. Only ATSM participants
demonstrated signiﬁcant improvements
relative to usual care participants in pa-
tient activation (Table A1, available in an
online appendix).
ATSM and GMV participants showed
similar improvements in diabetes self-
efﬁcacy relative to usual care participants
(effect size 0.41, P  0.01, and 0.38, P 
0.01), with no signiﬁcant differences be-
tween ATSM and GMV participants. In
contrast, participants in ATSM reported
improvements in interpersonal commu-
nication relative to both the usual care
(0.50, P  0.001) and GMV participants
(0.31, P  0.03). For the IPC subscales,
ATSM yielded signiﬁcant improvements
relative to usual care in explanations of
processes of care, explanations of self-
care, and empowerment and signiﬁcant
improvements relative to both usual care
and GMV in elicitation of patient prob-
lems and decision-making (Table A1).
Effects on behavior
Compared with usual care participants,
ATSM and GMV participants showed sig-
niﬁcant increases in self-management be-
havior (Table 2). The increase was more
robust for ATSM than for GMV partici-
pants (effect size 0.34, P  0.02). For in-
dividual self-management domains
(Table A1), both ATSM and GMV partic-
ipants improved with respect to self-
monitoring of blood glucose, but only
ATSM participants improved foot care.
Although ATSM and GMV participants
increased relative to usual care partici-
pants for diet and exercise, only ATSM
participants reported a signiﬁcant in-
crease in physical activity, with 2 more
h/week relative to usual care participants
(effect size 0.31, P  0.03).
In a comparison of baseline and fol-
low-up reports, a greater percentage of
ATSM participants achieved weekly min-
imum recommendations regarding phys-
ical activity of 30 min three times per
week(59.8vs.68.3%;oddsratio[OR]1.5
[95% CI 0.9–2.4]). There was little
change observed for GMV participants
(60.2 vs. 59.6%, 1.0 [0.6–1.5]) and a re-
duction in usual care participants (58.8
vs.53.3%;0.8[0.5–1.2]).Theinteraction
between the ratio of those achieving stan-
dards of physical activity at baseline ver-
sus follow-up was signiﬁcant in ATSM
participantsversususualcareparticipants
(P  0.05) but not in a comparison of
ATSM versus GMV participants (P 
0.50).
Effects on functional outcomes
ATSM participants reported signiﬁcant
decreases in days restricted to bed com-
pared with usual care participants (1.7
days/month, rate ratio 0.5 [95% CI 0.3–
1.0]) and with GMV participants (2.3
days/month, rate ratio 0.4 [0.2–0.7])
(Table 2). ATSM participants were less
likely to report that diabetes prevented
them from carrying out daily activities:
15% reported activity restriction at base-
line, compared with 6% at 1 year (OR
0.37[95%CI0.1–0.9]).Comparableval-
ues for GMV participants were 16 and
17% (1.0 [0.5–2.0]) and for usual care
participants were 17 and 21% (1.3 [0.7–
2.3]). The interaction between the pro-
portion reporting restricted activity at
Self-management support for vulnerable patients
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Baseline
12-Month
follow-up
Adjusted differences (95% CI) Standardized effect
size (adjusted) P values Relative to usual care ATSM vs. GMV
Structure of care
Patient assessment of chronic
illness care (summary
scale)
ATSM 36.8 (23.4) 58.9 (23.1) 12.2 (5.6 to 18.8) 0.51 0.0003
GMV 39.3 (26.6) 60.2 (27.2) 12.6 (6.0 to 19.2) 0.53 0.0002
Usual care 41.0 (24.2) 48.2 (26.5)
0.4 (7.0 to 6.1) 0.02 0.9
Processes of care
Diabetes self-efﬁcacy
ATSM 71.7 (17.3) 77.2 (14.6) 6.0 (2.0 to 10.1) 0.41 0.003
GMV 73.3 (16.1) 77.2 (15.0) 5.5 (1.4 to 9.6) 0.38 0.008
Usual care 73.5 (18.5) 71.7 (17.8)
0.5 (3.6 to 4.6) 0.04 0.8
Interpersonal processes of
care (summary scale)
ATSM 59.2 (20.3) 72.9 (15.4) 9.0 (4.0 to 13.9) 0.50 0.0004
GMV 63.4 (21.3) 68.9 (21.3) 3.3 (1.7 to 8.3) 0.18 0.2
Usual care 62.9 (20.6) 65.4 (21.1)
5.7 (0.7 to 10.7) 0.31 0.03
Behavioral outcomes
Self-management, weekly
(summary scale, in
days)
ATSM 3.7 (1.1) 4.4 (1.1) 0.6 (0.4 to 0.9) 0.62 0.0001
GMV 3.9 (1.2) 4.1 (1.1) 0.3 (0.01 to 0.6) 0.30 0.04
Usual care 3.9 (1.2) 3.8 (1.1)
0.3 (0.1 to 0.6) 0.34 0.02
Moderate physical activity,
weekly (min)
ATSM 206 325.0 123.9 (14.8 to 233.0) 0.31 0.03
GMV 285 320.5 69.1 (41.2 to 179.4) 0.17 0.2
Usual care 195 193.5
54.8 (62.1 to 186.3) 0.14 0.3
Vigorous exercise, weekly
(min)
ATSM 55 54.8 32.2 (9.8 to 74.2) 0.21 0.1
GMV 41 45.4 23.3 (19.0 to 65.5) 0.15 0.3
Usual care 67 23.0
8.9 (33.7 to 51.5) 0.06 0.7
Functional outcomes Rate ratio
Bed days, prior month
ATSM 3.8 (8.0) 1.4 (2.7) 1.7 (3.3 to 0.1) 0.5 (0.3, 1.0) 0.05
GMV 3.6 (7.0) 3.6 (7.5) 0.6 (1.0 to 2.2) 1.4 (0.7, 2.9) 0.3
Usual care 3.9 (7.6) 3.1 (7.2)
2.3 (3.9 to 0.4) 0.4 (0.2–0.7) 0.004
Restricted activity (% 
often/always)
ATSM 14.9 6.0 0.4 (0.01 to 0.9)* 0.03*
GMV 16.3 16.2 1.0 (0.5 to 1.9) 0.9
Usual care 17.1 21.0 1.3 (0.7 to 2.3) 0.4
SF-12 mental health
ATSM 57.2 (28.1) 67.0 (25.8) 3.7 (2.0 to 9.4) 0.18 0.2
GMV 61.7 (24.0) 63.0 (24.0) 2.9 (8.6 to 2.9) 0.15 0.3
Usual care 58.8 (26.7) 64.2 (27.2)
6.5 (0.7 to 12.4) 0.31 0.03
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icant for ATSM versus GMV participants
(P  0.6) but was for ATSM versus usual
care participants (P  0.04). Although
SF-12 physical health increased across all
three groups, there were no statistically
signiﬁcant differences between ATSM,
GMV, and usual care participants. SF-12
mental health differentially improved for
ATSM relative to GMV (effect size 0.31,
P  0.03) and usual care (effect size 0.18,
P  0.2) participants.
Effects on metabolic outcomes
Glycemic control improved across all
three arms, but there were no statistically
signiﬁcant differences in A1C change be-
tween ATSM, GMV, and usual care par-
ticipants. Although SBP and DBP fell in
both the ATSM and GMV arms relative to
the usual care arm, these values did not
reach statistical signiﬁcance. Changes in
BMI were not different across the three
arms.
Post hoc analyses
Tobetterunderstandourﬁndingsregard-
ing the relative superiority of ATSM over
GMV, we carried out two post hoc analy-
ses. To test whether the different engage-
ment rates might explain observed
differences in behavioral and functional
outcomes, we created a standardized,
three-level variable that categorized par-
ticipant engagement into low, medium,
and high. Whereas greater engagement
wasassociatedwithimprovementsinself-
management behavior and functional sta-
tus in both SMS arms, including this
variable as a covariate in our models did
not alter the size of the effect of ATSM
relative to that of GMV for either out-
come.Toexplorewhetherdisproportion-
ate improvements in IPC observed in
ATSM versus GMV mediated differences
in behavioral and functional outcomes,
we reran self-management and bed-day
models, including IPC scores as an addi-
tional covariate. Inclusion of IPC scores
reduced the effect of ATSM versus GMV
for self-management behavior from 0.33
days/week (P  0.02) to 0.25 days/week
(P  0.07) and reduced the rate ratio in
bed days from 0.35 (P  0.01) to 0.45
(P  0.03).
CONCLUSIONS — We performed
an effectiveness study of SMS using a
three-arm practical clinical trial design
among linguistically and ethnically di-
verse, low-income diabetic patients in a
safety net system. To our knowledge, this
represents the ﬁrst study to compare dif-
ferent forms of diabetes SMS with usual
care. We found that providing tailored
SMS using patient-generated behavioral
action plans resulted in improvements in
patients’ experiences with chronic illness
care, self-efﬁcacy, and self-management
behaviors. The ATSM model yielded
more robust and consistent improve-
ments across many levels of the CCM and
was uniquely associated with improve-
ments in interpersonal processes of care,
physical activity, and functional status,
Table 2—Continued
Baseline
12-Month
follow-up
Adjusted differences (95% CI) Standardized effect
size (adjusted) P Relative to usual care ATSM vs. GMV
SF-12 physical health
ATSM 51.3 (30.0) 60.2 (29.1) 2.7 (4.0 to 9.5) 0.11 0.4
GMV 50.9 (29.5) 57.1 (29.7) 0.1 (6.9 to 6.7) 0.01 1.0
Usual care 50.0 (30.5) 56.7 (31.3)
2.9 (4.0 to 9.7) 0.12 0.4
Metabolic outcomes
A1C (%)
ATSM (n  101) 9.3 (1.7) 8.7 (1.9) 0.1 (0.5 to 0.4) 0.04 0.8
GMV (n  96) 9.3 (1.9) 9.0 (2.0) 0.2 (0.2 to 0.7) 0.14 0.3
Usual care (n  103) 9.8 (2.1) 9.0 (2.2)
0.3 (0.8 to 0.2) 0.18 0.2
SBP (mmHg)
ATSM (n  107) 136.9 (21.4) 136.9 (20.4) 3.2 (8.3 to 1.9) 0.19 0.2
GMV (n  104) 142.4 (19.8) 138.9 (20.3) 3.9 (9.0 to 1.2) 0.23 0.1
Usual care (n  108) 139.6 (20.8) 141.5 (23.9)
0.7 (4.5 to 5.9) 0.04 0.8
DBP (mmHg)
ATSM (n  107) 75.0 (11.8) 75.4 (12.3) 1.6 (5.1 to 2.0) 0.14 0.4
GMV (n  104) 78.1 (12.7) 75.5 (11.3) 3.1 (6.6 to 0.4) 0.26 0.08
Usual care (n  108) 78.1 (10.9) 78.5 (18.5)
1.5 (2.0 to 5.1) 0.13 0.4
BMI (kg/m
2)
ATSM (n  104) 30.3 (6.8) 30.7 (6.9) 0.1 (0.4 to 0.5) 0.06 0.8
GMV (n  104) 32.1 (8.2) 32.4 (8.4) 0.02 (0.5 to 0.5) 0.01 0.9
Usual care (n  105) 31.2 (8.7) 31.4 (8.5)
0.1 (0.4 to 0.5) 0.06 0.8
Baseline and 12-month follow-up data are on a 0–100 scale unless otherwise indicated. For ATSM, n  101; for GMV, n  99, and for usual care, n  105, unless
otherwise speciﬁed. *Data are ORs for change within ATSM that is signiﬁcantly different from change within usual care (OR 0.4 vs. 1.3, P  0.02); GMV is not
signiﬁcantly different from usual care or ATSM (P  0.20).
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ularly effective for vulnerable popula-
tions.ThatthedifferencesbetweenATSM
and GMV participants with respect to be-
haviorandfunctionalstatuswerereduced
when we included interpersonal pro-
cesses of care as a mediator suggests that
communication characteristics inherent
to the ATSM model, such as its proactive
nature or hierarchical logic (capacity to
trigger telephonic information or nurse
call-backs contingent on patient re-
sponses) may have preferentially acti-
vated those with greater SMS needs.
Our ﬁndings are consistent with re-
search in other settings and support the
versatility of ATSM methodology. Efﬁ-
cacy studies of ATSM linked to nurse care
management demonstrated improve-
ments in self-efﬁcacy and functional sta-
tus (11) but did not show effects on diet
or physical activity. As with our study,
there was little effect of ATSM with re-
spect to glycemic control, although posi-
tive effects on glycemic control for a
subgroup with poor control were
reported.
OurmixedresultsregardingtheGMV
model are also noteworthy. Prior studies
of GMVs have not been population-
based, with enrollment of only those re-
porting a very high level of interest in
attending GMVs (21), or reported out-
comes among subjects who attended
groups and compared them with wait-list
control subjects irrespective of ultimate
attendance (14). As the GMV model has
begun to diffuse into practice, there is ev-
idence that it improves processes of care
but has little effect on metabolic out-
comes. Only one-half to two-thirds of pa-
tients report any interest in attending
GMVs (22). We used a population-based
strategy to identify and enroll all eligible,
consenting participants, regardless of the
extent of their reported willingness to at-
tend GMVs or respond to ATSM calls. Al-
though we have previously reported a
lowerrateofparticipationforGMVscom-
pared with ATSM (10), our post hoc
analysissuggeststhatdifferencesinpar-
ticipation do not explain the dispropor-
tionate improvements observed for
ATSM participants.
There are a number of possible expla-
nations for the lack of effect on metabolic
outcomes.First,becauseweonlyenrolled
participants who had A1C of 8.0%, all
three arms were subject to regression to
themean.Second,thesamplesizewastoo
small to detect modest changes in glyce-
mic control. Recent controlled studies of
telephone-based counseling and other
forms of SMS suggest that A1C tends to
fall by only 0.3% (5,23,24). Third, ob-
served improvements in self-manage-
ment behavior may not, in isolation, lead
to rapid and clinically signiﬁcant im-
provements in glycemic control. In addi-
tion, we found no evidence that
participants were more likely to be tak-
ing insulin or other hypoglycemic med-
ications as a result of exposure to either
SMS arm (data not shown). Interven-
tions that provide decision support to
patients and clinicians regarding medi-
cation intensiﬁcation may be required
to improve clinical metrics.
Although the lack of effect on meta-
bolic indicators in response to SMS expo-
sure is noteworthy, the beneﬁcial effects
on patient-reported diabetes behavior
and functional outcomes in ATSM are
both clinically relevant and meaningful
from the patients’ perspective. Increases
inphysicalactivity,forexample,canyield
improvements in cardiovascular ﬁtness
and functional status, independent of as-
sociated weight loss, glycemic control, or
reductions in blood pressure. Similarly,
because diabetes is strongly associated
with functional decline and progression
to disability, the reduction in number of
days spent bed-bound in ATSM partici-
pants represents an important short-term
beneﬁt for a sample of whom more than
three-fourthsreportedfairorpoorhealth.
Measures of restricted activity, such as
bed days, are robust predictors of func-
tional decline among community-
dwelling individuals with chronic disease
(20).
Study strengths include a random-
ized design, population-based recruit-
ment, a safety net setting, a multilingual
population with a range of literacy skills,
the implementation of linguistically tai-
lored SMS embedded in, rather than
“carved out” of, primary care (5), high
rates of participant follow-up, and use of
validated outcome measures. There are a
number of limitations to this study. First,
although the practical clinical trial design
increased external validity (9), interven-
tions took place in one safety net health
system. Second, many study end points
were captured by patient report. Because
thestudywasnotblindedandbecausethe
usual care group did not receive any ad-
ditional SMS intervention, systematic in-
accuracies in patient-reported outcomes
may have occurred due to recall bias or
social desirability. The measures of self-
management behavior and functional sta-
tus used have been shown to be reliable
and valid indicators of objective health
measures, the research assistants were
masked to participants’ group assign-
ment, and the randomized design re-
duced the likelihood of an intervention-
speciﬁc bias, particularly given the
differential changes in outcomes ob-
served between interventions. Third, we
cannotdeterminewhetherdifferencesbe-
tween the ATSM and GMV models re-
sulted from their different structures,
program logic, periodicity, or levels of in-
tensity. Fourth, the study was not ade-
quately powered to provide deﬁnitive
answers regarding relative impacts across
subgroups, such as those with limited
Englishproﬁciencyandlimitedliteracy.
Finally, although start-up and imple-
mentation costs of the ATSM and GMV
programs were similar, a formal cost-
effectiveness analysis was beyond the
scope of this report but is the subject of
a companion article (25).
In summary, traditional SMS ap-
proaches often do not reach signiﬁcant
segments of the population with chronic
disease, such as individuals who are un-
insured or publicly insured or those with
communication barriers, such as limited
literacy or limited English proﬁciency
(26). This represents a signiﬁcant limita-
tion with respect to realizing the public
health beneﬁts of SMS. Although imple-
menting elements of the CCM in commu-
nity health centers can improve quality
indicators (7), there is little translational
research as to how to improve patient-
reported outcomes in safety net settings
(5). Providing tailored SMS for linguisti-
cally and ethnically diverse diabetic pa-
tients in a safety net system resulted in
improvements in patients’ experiences
with chronic illness care, self-efﬁcacy,
and self-management behaviors. The
ATSM model, which combines accessible
technology with targeted interpersonal
support, yielded more robust and consis-
tent improvements across many levels of
theCCM,includingfunctionalstatus.For
health system planners, our study sug-
gests that ATSM is a more effective com-
munication vehicle than GMV to deliver
population-based SMS and improve
health-promoting behavior and quality of
life. For SMS programs to also translate
into improvements in metabolic indica-
tors, they may need to be combined with
additional features of the CCM, such as
decision support regarding medication
intensiﬁcation.
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